PhRMA Statement Supporting U.S. Economic Recovery Advisers

Washington, D.C. (Jan. 21, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today regarding the President’s new economic recovery advisory board:

“PhRMA commends President Obama for establishing a new Council on Jobs and Competitiveness, to be led by General Electric Chief Executive Officer Jeffrey R. Immelt.

Improving Prescription Medicine Adherence

Backgrounder: Improving Prescription Medication Adherence is Key to Better Health Care

Driving State Economic Growth in the 21st Century: Advancing the Biopharmaceutical Sector Report

Driving State Economic Growth in the 21st Century Executive Summary

PhRMA Statement on Health Care Reform

Washington, D.C. (March 25, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement on passage of comprehensive health care reform and accompanying reconciliation legislation:

“We believe comprehensive health care reform will benefit patients and the future of America. That’s why we have been involved in this important public policy debate for more than a year and why we supported the final health care reform bill and the amendments found in the reconciliation legislation.

PhRMA Statement on Senate Health Care Reform Bill

Washington, D.C. (December 24, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement about the Senate health care reform bill:

House Tri-Committee Bill Would Hurt Patients and Kill Jobs

Washington, D.C. (July 31, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement after the Energy and Commerce Committee mark-up of the House Tri-Committee bill:

PhRMA Statement on HELP Committee Health Reform Vote

Washington, D.C. (July 15, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the Senate Health, Education, Labor and Pensions Committee’s vote in favor of the “Quality, Affordable Health Coverage for All Americans” bill:

PhRMA Statement on House Tri-Committee Health Reform Bill

Washington, D.C. (July 14, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement about the House Tri-Committee health care reform bill:

Pages

Subscribe to RSS - Value